Published in TB and Outbreaks Week, August 27th, 2002
Vical's president and CEO, Vijay B. Samant, said, "Over the last several years, Vical has developed significant expertise and infrastructure, and has become recognized as a reliable manufacturer of clinical-grade (cGMP) plasmid DNA. We are pleased to support the VRC's Ebola vaccine program, which has potential for prevention of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.